A detailed history of Boston Family Office LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Boston Family Office LLC holds 9,342 shares of MRNA stock, worth $344,252. This represents 0.04% of its overall portfolio holdings.

Number of Shares
9,342
Previous 5,084 83.75%
Holding current value
$344,252
Previous $604,000 3.31%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$63.64 - $125.14 $270,979 - $532,846
4,258 Added 83.75%
9,342 $624,000
Q2 2024

Aug 12, 2024

BUY
$101.21 - $166.61 $277,416 - $456,678
2,741 Added 116.99%
5,084 $604,000
Q1 2024

May 13, 2024

BUY
$85.37 - $115.44 $27,233 - $36,825
319 Added 15.76%
2,343 $250,000
Q4 2023

Feb 12, 2024

BUY
$69.51 - $104.43 $140,688 - $211,366
2,024 New
2,024 $201,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Boston Family Office LLC Portfolio

Follow Boston Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Family Office LLC with notifications on news.